These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7628151)

  • 21. Concentration of Tc-99m MDP in ovarian carcinoma and its soft tissue metastases.
    Beres RA; Patel N; Krasnow AZ; Isitman AT; Hellman RS; Veluvolu P; Patillo RS; Collier BD
    Clin Nucl Med; 1991 Aug; 16(8):550-2. PubMed ID: 1934805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization of papillary thyroid carcinoma and its metastatic lymph nodes. Images with Tc-99m pertechnetate, Tl-201, and Tc-99m sestamibi.
    Alper E; Akbunar T; Tamgac F
    Clin Nucl Med; 1996 Oct; 21(10):815-6. PubMed ID: 8896938
    [No Abstract]   [Full Text] [Related]  

  • 24. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor.
    Campeau RJ; Kronemer KA; Sutherland CM
    Clin Nucl Med; 1992 Dec; 17(12):936-7. PubMed ID: 1334449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
    Line BR; Feustel PJ; Festin SM; Andersen TT; Dansereau RN; Lukasiewicz RL; Zhu S; Bennett JA
    Cancer Biother Radiopharm; 1999 Dec; 14(6):485-94. PubMed ID: 10850335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value and throughput of rest Thallium-201/stress Technetium -99m sestamibi dual-isotope myocardial SPECT.
    Okudan B; Smitherman TC
    Anadolu Kardiyol Derg; 2004 Jun; 4(2):161-8. PubMed ID: 15165953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
    Ozcan Z; Erenel G; Aksoylar S; Kansoy S; Burak Z; Ozkiliç H
    Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomatous transformation of neurofibromas. Comparative imaging with Ga-67, Tl-201, Tc-99m pentavalent DMSA and Tc-99m MIBI.
    Lee J; Sohn SK; Ahn BC; Chun KA; Lee K; Kim CK
    Clin Nucl Med; 1997 Sep; 22(9):610-4. PubMed ID: 9298294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201.
    Aktolun C; Bayhan H; Kir M
    Clin Nucl Med; 1992 Mar; 17(3):171-6. PubMed ID: 1611785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone scan appearance in aggressive osteogenic sarcoma with pleural, lung, bone, and soft-tissue metastases.
    Othman S; El-Desouki M
    Clin Nucl Med; 2003 Nov; 28(11):926. PubMed ID: 14578712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Tc-99m MDP and Ga-67 imaging in the clinical evaluation of malignant fibrous histiocytoma.
    Lin WY; Kao CH; Hsu CY; Liao SQ; Wang SJ; Yeh SH
    Clin Nucl Med; 1994 Nov; 19(11):996-1000. PubMed ID: 7842598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.
    Calnon DA; Ruiz M; Vanzetto G; Watson DD; Beller GA; Glover DK
    Circulation; 1999 Oct; 100(15):1653-9. PubMed ID: 10517738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma.
    Kashitani N; Makihara S; Maeda T; Eda R; Takeyama H; Hiraki Y
    Oncol Rep; 1999; 6(1):127-33. PubMed ID: 9864415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
    Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tl-201 chloride and Tc-99m MIBI accumulation in lung adenocarcinoma in patients with and without distant metastases.
    Yamamoto Y; Nishiyama Y; Fukunaga K; Satoh K; Ohkawa M
    Clin Nucl Med; 2001 Sep; 26(9):751-6. PubMed ID: 11507291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
    Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tc-99m MIBI/Tc-99m MDP mismatch: a useful scintigraphic finding in differentiating myositis ossificans from malignant tumor of soft tissue.
    Khoury J; Jerushalmi J; Loberant N
    Clin Nucl Med; 2006 Sep; 31(9):547-9. PubMed ID: 16921280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.